03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Voltfast* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Khalil Fattal & Fils |
Distributor | Khalil Fattal & Fils |
Laboratory | Novartis |
Manufacturer | Pharmaline SAL* |
Manufacturing Type | Licensed by Novartis Pharma AG |
Origin | Lebanon |
ATC | M01AB05 |
Voltfast* :
Voltfast* :
Voltfast* :
Voltfast* :
Voltfast* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Agranulocytosis | Very rare |
Alopecia | Very rare |
Anaemia | Very rare |
Anaphylactic reactions | Rare |
Anaphylactoid reactions | Rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Anxiety | Very rare |
Aplastic anemia | Very rare |
Asthma | Rare |
Auditory hypoacuity | Very rare |
Bloody diarrhea | Rare |
Cardiac failure | Uncommon |
Cephalea | Common |
Cerebrovascular accident | Very rare |
Chest pain | Uncommon |
Colitis | Very rare |
Colitis ulcerative | Very rare |
Constipation | Very rare |
Convulsion | Very rare |
Crohn's disease | Very rare |
Decreased appetite | Common |
Depression | Very rare |
Dermatitis bullous | Very rare |
Dermatitis exfoliative | Very rare |
Diarrhoea (Diarrhea) | Common |
Diplopia | Very rare |
Disorientation | Very rare |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very rare |
Dyspepsia | Common |
Dyspnoea (dyspnea) | Rare |
Eczema | Very rare |
Erythema | Very rare |
Erythema multiforme | Very rare |
Face oedema | Very rare |
Flatulence | Common |
Fluid retention | Common |
Gastritis | Rare |
Gastroduodenal haemorrhage | Rare |
Gastrointestinal perforation | Rare |
Gastrointestinal ulcer | Rare |
Glossitis | Very rare |
Haematemesis | Rare |
Haematuria (Hematuria) | Very rare |
Haemolytic anemia | Very rare |
Hemorrhagic colitis | Very rare |
Henoch-Schönlein purpura | Very rare |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Rare |
Hepatic necrosis | Very rare |
Hepatitis | Rare |
Hepatitis fulminant | Very rare |
Hypersensitivity | Rare |
Hypertension | Common |
Hypotension | Rare |
Insomnia | Very rare |
Intestinal diaphragm disease | Very rare |
Irritability | Very rare |
Jaundice | Rare |
Leucopenia (Leukopenia) | Very rare |
Lightheadedness | Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Very rare |
Melaena | Rare |
Memory impairment | Very rare |
Meningitis aseptic | Very rare |
Myocardial infarction | Uncommon |
Nausea | Common |
Nephrotic syndrome | Very rare |
Nightmares | Very rare |
Oedema | Common |
Oesophageal disorder | Very rare |
Palpitations | Uncommon |
Pancreatitis | Very rare |
Paraesthesia (paresthesia) | Very rare |
Photosensitivity reaction | Very rare |
Pneumonia | Very rare |
Proteinuria | Very rare |
Pruritus | Very rare |
Psychotic disorders | Very rare |
Purpura | Very rare |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Very rare |
Renal papillary necrosis | Very rare |
Shock | Rare |
Skin Eruption | Common |
Somnolence | Rare |
Stevens-Johnson syndrome | Very rare |
Stomatitis | Very rare |
Thrombocytopenia (Thrombopenia) | Very rare |
Tinnitus | Very rare |
Transaminases increased | Common |
Tremor | Very rare |
Tubulointerstitial nephritis | Very rare |
Urticaria | Rare |
Vasculitides | Very rare |
Vertigo | Common |
Vision decreased | Very rare |
Visual disturbance | Very rare |
Vomiting | Common |
Voltfast* :
NB : Products With Same Indication |
Different Units By MoH Code
Voltfast* MoH 6639 :
Form | Powder for oral solution |
Packaging | Sachets (paper / Al / PE) |
Package Size | Box of 30 |
Strength | 50mg |
Storage Condition | <25°C Away from moisture |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 166755/11 |
Submission date | 01/01/2011 |
Registration Year | 2012 |
Archived Date | 02/03/2021 |
Price Comparison
● Country: | Switzerland | |
● Package Size: | 10 | |
● Public Price: | 17.75 CHF | ( 1,835,705.00 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 1,775 CHF | ( 103,420.00 LBP ) |
● Exfactory Price: | 8.31 CHF | |
● Pricing Date: | 20/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 30 | |
● Public Price: | 62 QAR | ( 1,522,596.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2,0667 QAR | ( 49,116.00 LBP ) |
● Pharmacy Price: | 50.490227762 QAR | ( 1239939.0133792 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 30 | |
● Public Price: | 70.5 AED | ( 1,703,350.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2,35 AED | ( 48,322.00 LBP ) |
● Pharmacy Price: | 57.02 AED | ( 1377660.22 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 30 Sachets | |
● Public Price: | 70.5 AED | ( 1,703,350.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2,35 AED | ( 48,322.00 LBP ) |
● Pharmacy Price: | 57.02 AED | ( 1377660.22 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 30 | |
● Public Price: | 6.47 OMR | ( 1,492,848.98 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,2157 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 30 | |
● Public Price: | 4.39 JOD | ( 549,720.19 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,1463 JOD | ( 0.00 LBP ) |
● Pharmacy Price: | 3.35 JOD | ( 419490.35 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 30 | |
● Public Price: | 5.9 BHD | ( 1,402,630.60 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,1967 BHD | ( 0.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 30UNITA | |
● Public Price: | 5.24 EUR | ( 507,630.24 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,1747 EUR | ( 0.00 LBP ) |
● Pricing Date: | 15/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | Boîte de 30 | |
● Public Price: | 5.04 KWD | ( 1,479,648.24 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,168 KWD | ( 0.00 LBP ) |
● Pharmacy Price: | 4.26 KWD | ( 1250655.06 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Finland |
● Package Size: | 30 |
● Reference: | Kela |
● Pricing Date: | 24/10/2020 |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File